561
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Antiangiogenic Effect of a Chinese Sweet Leaf Tea Extract in Experimental Corneal Neovascularization

, , , , , , & show all
Pages 44-47 | Accepted 27 Jul 2006, Published online: 07 Oct 2008
 

Abstract

This study was undertaken to evaluate the effect of topical administration of Rubus suavissimus. S. Lee (Rosaceae) (RUS), an extract of Chinese sweet leaf tea, in the prevention of experimentally induced corneal neovascularization. Corneal neovascularization was induced in 40 rat eyes (1 per animal) by a silver nitrate cauterization technique. Three concentrations (0.1%, 1%, and 10% w/v) of RUS in saline were administered topically twice a day for 7 days. The coverage of the corneal surface by neovascular vessels was measured, using photographs, as a percentage of total cornea area. A histopathologic score was assigned to each cornea. The difference in mean burn stimulus scores of treatment and placebo groups was not statistically significant (p = 0.714). The 10% RUS solution caused a significant decrease in the percentage of neovascularization in response to cauterization (p < 0.01); the 0.1% and 1% concentrations were not significantly different from controls (p = 0.173). The 10% concentration group had significantly less neovascularization than the control group (p < 0.01). It was found that topical application of 10% RUS solution caused a significant decrease in neovascular response to silver nitrate cauterization compared with control eyes.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.